TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 117 filers reported holding TG THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,952,032 | -56.3% | 951,200 | +29.8% | 0.02% | -56.5% |
| Q2 2023 | $18,197,784 | +131.1% | 732,600 | +39.9% | 0.05% | +130.0% |
| Q1 2023 | $7,874,944 | +91.7% | 523,600 | +50.8% | 0.02% | +81.8% |
| Q4 2022 | $4,108,559 | +239.0% | 347,300 | +69.7% | 0.01% | +175.0% |
| Q3 2022 | $1,212,000 | +90.9% | 204,700 | +37.0% | 0.00% | +100.0% |
| Q2 2022 | $635,000 | -16.9% | 149,400 | +86.1% | 0.00% | 0.0% |
| Q1 2022 | $764,000 | +101.1% | 80,300 | +1000.0% | 0.00% | +100.0% |
| Q4 2020 | $380,000 | +4.7% | 7,300 | -83.8% | 0.00% | 0.0% |
| Q1 2019 | $363,000 | +58.5% | 45,200 | -19.0% | 0.00% | 0.0% |
| Q4 2018 | $229,000 | -5.0% | 55,800 | +29.8% | 0.00% | 0.0% |
| Q3 2018 | $241,000 | -64.8% | 43,000 | -17.5% | 0.00% | -50.0% |
| Q2 2018 | $685,000 | +57.1% | 52,100 | +69.7% | 0.00% | +100.0% |
| Q1 2018 | $436,000 | +260.3% | 30,700 | +201.0% | 0.00% | – |
| Q3 2017 | $121,000 | -2.4% | 10,200 | -17.1% | 0.00% | – |
| Q2 2017 | $124,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |